Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2007-04-03
2007-04-03
Graser, Jennifer E. (Department: 1645)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S300000, C530S350000, C530S388100, C530S351000, C435S226000, C435S219000
Reexamination Certificate
active
10423729
ABSTRACT:
A metalloprotease that converts TNF-α from the 26 kD cell form to the 17 kD form has been isolated and purified and the cDNA sequence known. In particular, the protease has a molecular weight of approximately 80 kD. The isolated and purified protease is useful for designing an inhibitor thereof, and may find use as a therapeutic agent. Assays for detecting the protease-inhibiting activity of a molecule are also an aspect of the invention.
REFERENCES:
patent: 5422425 (1995-06-01), Krieger
patent: 5545518 (1996-08-01), Krieger
patent: 5594106 (1997-01-01), Black
patent: 5629285 (1997-05-01), Black
patent: 5691382 (1997-11-01), Crimmin
patent: 5702705 (1997-12-01), Kriegler
patent: 5753653 (1998-05-01), Bender
patent: 5830742 (1998-11-01), Black
patent: 5998378 (1999-12-01), Krieger
patent: 6013466 (2000-01-01), Black
patent: 6180403 (2001-01-01), Fluornoy
patent: 0 592 423 (2000-11-01), None
patent: WO91/02756 (1991-03-01), None
patent: WO92/00378 (1992-01-01), None
patent: WO92/02822 (1992-02-01), None
patent: WO94/00555 (1994-01-01), None
patent: WO94/10990 (1994-05-01), None
patent: WO94/24140 (1994-10-01), None
patent: WO95/06031 (1995-03-01), None
patent: WO95/09841 (1995-04-01), None
patent: WO95/24501 (1995-09-01), None
patent: WO96/33176 (1996-10-01), None
patent: WO96/35712 (1996-11-01), None
patent: WO96/35714 (1996-11-01), None
patent: WO97/35538 (1997-10-01), None
patent: WO99/40182 (1999-08-01), None
patent: WO99/40182 (1999-08-01), None
patent: WO00/09492 (2000-02-01), None
patent: WO91/02540 (2001-03-01), None
U.S. Appl. No. 09/244,984, filed Feb 4, 1999, Black.
Krieger et al., “A Novel Form of TNF/Cachectin is a Cell Surface Cytotoxic Transmembrane Protein: Ramifications for the Complex Physiology of TNF,”Cell535-53, 1988.
Scuderi, P., “Suppression of Human Leukocyte Tumor Necrosis Factor Secretion by the Serine Protease Inhibitorp-Toluenesulfonyl-L-Arginine Methyl Ester (TAME),”J. Immunology143 168-173, 1989.
Davis B et al., “A Synthetic Matrix Metalloproteinase Inhibitor Decreases Tumor Burden and Prolongs Survival of Mice Bearing Human Ovarian Carcinoma Xenografts,”Cancer Res. 53:2087-2091, 1993.
Hell, W., et al., “Cleavage of tumor necrosis factor-α by Legionella exoprotease,”APMIS101:120-126, 1993.
Mohler, K. et al., “Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing,”Nature370:218-220, 1994.
Gearing, A. et al., “Processing of Tumour necrosis factor-α precursor by metalloproteinases,”Nature370:555-557, 1994.
McGeehan, G. et al., “Regulation of tumour necrosis factorα processing by a metalloproteinase inhibitor,”Nature370:558-561, 1994.
Black et al., “Cloning of a Membrane-Bound TNFα Converting Enzyme (TACE),”Eur Cytokine Netw7:180, Apr.-Jun. 1996.
Moss M., et al., “Structural Features and Biochemical Properties of TNF-Alpha Convertase,”Eur. Cytokine Netw. 7:181, Apr.-Jun. 1996.
Gearing A. “ATNF and Matrix Mettaloproteinase Inhibitors,”,Eur. Cytokine Netw. 7:284, Apr.-Jun. 1996.
Liedtke W., et al., “A Matrix Mettaloprotease Inhibitor is Effective in Acute and Chronic Recurrent Experimental Allergic Encephalomyelitis (EAE),”Eur. Cytokine Netw. 7:284, Apr.-Jun. 1996.
Wallach D., “A Decade of Accumulated Knowledge and Emerging Answers,”Eur. Cytokine Netw. 7:713-724, Dec. 1996.
Black, R. et al. “A Metalloproteinase Disintegrin that Releases Tumour-Necrosis Factor-α from Cells,”Nature385:729-732, 1997.
Moss, M. et al., “Cloning of a Disintegrin Metalloproteinase that Processes Precursor Tumour Necrosis Factor α,”Nature385: 733-736, 1997.
Armour, A. et al., “TNF-alpha Converting Enzyme (TACE) is Inhibited by TIMP-3,”FEBS lett. 435:39-44, 1998.
Black Roy A
Cerretti Douglas P
March Carl J
Rauch Charles
Graser Jennifer E.
Immunex Corporation
Lingenfelter Susan E.
Sprunger Suzanne A.
LandOfFree
Antibodies that bind TNF-α converting enzyme does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies that bind TNF-α converting enzyme, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies that bind TNF-α converting enzyme will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3762135